Senyo Health App for Substance Abuse in Bipolar Disorder

This trial tests a new app called Senyo Health, designed to help individuals with bipolar disorder manage substance use, such as alcohol consumption. The main goal is to determine if the app can improve adherence to treatment and reduce the frequency and quantity of substance use. This study suits individuals with bipolar disorder who also struggle with alcohol use and have access to a smartphone for daily app use.

As an unphased trial, it offers participants a unique opportunity to contribute to innovative research that could enhance treatment strategies for bipolar disorder and substance use.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that digital tools like the Senyo Health app can safely assist in treating substance use disorder (SUD). Other studies have found that people generally find digital health tools easy to use. For instance, one study demonstrated that patients using a smartphone app for self-monitoring used it consistently. They also experienced improvements in symptoms related to bipolar disorder, with depressive symptoms decreasing by 41%, manic symptoms by 46%, and overall symptom instability by 39%.

Researchers are excited about the Senyo Health app because it offers a novel approach to managing substance abuse in individuals with bipolar disorder. Unlike traditional treatments, which often rely on medication and therapy, the Senyo Health app provides a digital, interactive platform that users engage with daily for 12 weeks. This app leverages technology to deliver personalized support and track progress in real-time, potentially increasing accessibility and engagement for patients who may struggle with regular in-person treatment sessions. The use of a digital tool is particularly promising as it could offer a more flexible and immediate form of assistance, helping to address the unique challenges faced by this population.

Studies have shown that the Senyo Health app can help people reduce their substance use. It employs a digital platform to support patients and healthcare providers with SBIRT, which stands for Screening, Brief Intervention, and Referral to Treatment. Research indicates that users of this app often reduce their substance use more than those relying on traditional treatments. In this trial, participants will use the Senyo Health app daily for 12 weeks. The app aims to keep individuals engaged in their treatment, which is crucial for managing substance use in those with bipolar disorder. Early findings suggest that this type of digital support can improve outcomes for individuals dealing with both bipolar disorder and substance use issues.¹²⁴⁵⁶